Stochastic cost-effectiveness analysis on population benefits

被引:0
|
作者
Ermo Chen
机构
[1] Peking University,School of Mathematical Sciences
关键词
Stochastic cost-effectiveness analysis; Population benefits; Risk allocation; Return on risk;
D O I
暂无
中图分类号
学科分类号
摘要
Dealing with randomness is a crucial aspect that cost-effectiveness analysis (CEA) tools need to address, but existing stochastic CEA tools have rarely examined risk and return from the perspective of population benefits, concerning the benefits of a group of individuals but not just a typical one. This paper proposes a stochastic CEA tool that supports medical decision-making from the perspective of population benefits of risk and return, the risk-adjusted incremental cost-effectiveness ratio (ICER). The tool has a traditional form of ICER but uses the cost under a risk-adjusted expectation. Theoretically, we prove that the tool can provide medical decisions trimming that promote the risk-return level on population benefits within any intervention structure and can also serve as a criterion for the optimal intervention structure. Numerical simulations within a framework of mean–variance support the conclusions in this paper.
引用
收藏
相关论文
共 50 条
  • [21] Videonystagmography: Cost-Effectiveness and Benefits Study Comment
    Bloedow, Alexander
    LARYNGO-RHINO-OTOLOGIE, 2021, 100 (06)
  • [22] Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis
    Marklund, Matti
    Aminde, Leopold N.
    Wanjau, Mary Njeri
    Huang, Liping
    Awuor, Celine
    Steele, Lindsay
    Cobb, Laura K.
    Veerman, J. Lennert
    Wu, Jason H. Y.
    BMJ GLOBAL HEALTH, 2023, 8 (10):
  • [23] Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans-fatty acids in Nigeria: cost-effectiveness analysis
    Marklund, Matti
    Aminde, Leopold N.
    Wanjau, Mary Njeri
    Ale, Boni M.
    Ojo, Adedayo E.
    Okoro, Clementina E.
    Adegboye, Abimbola
    Huang, Liping
    Veerman, J. Lennert
    Wu, Jason H. Y.
    Huffman, Mark D.
    Ojji, Dike B.
    BMJ GLOBAL HEALTH, 2024, 9 (04):
  • [24] Uncertainty in cost-effectiveness analysis - Probabilistic uncertainty analysis and Stochastic league tables
    Baltussen, RMPM
    Hutubessy, RCW
    Evans, DB
    Murray, CJM
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (01) : 112 - 119
  • [25] COST-EFFECTIVENESS AND COST BENEFITS OF COMMERCIAL INFORMATION-SERVICES
    CAWKELL, A
    GARFIELD, E
    CURRENT CONTENTS, 1975, (34): : 6 - 10
  • [26] COST-EFFECTIVENESS ANALYSIS OF NUVAXOVID VACCINATION FOR JAPANESE ELDERLY POPULATION
    Kato, M.
    VALUE IN HEALTH, 2023, 26 (12) : S137 - S137
  • [27] Cost-effectiveness analysis of screening for Celiac disease in the adult population
    Shamir, Raanan
    Hernell, Olle
    Leshno, Moshe
    MEDICAL DECISION MAKING, 2006, 26 (03) : 282 - 293
  • [28] Who should be prioritized for HCV antiviral treatment? A cost-effectiveness analysis including individual and population prevention benefits
    Martin, Natasha K.
    Vickerman, Peter
    Dore, Gregory J.
    Grebely, Jason
    Foster, Graham R.
    Miners, Alec
    Hutchinson, Sharon
    Goldberg, David J.
    Martin, Thomas C.
    HEPATOLOGY, 2014, 60 : 1042A - 1042A
  • [29] COST-EFFECTIVENESS ANALYSIS OF BICYCLE HELMET SUBSIDIES IN A DEFINED POPULATION
    THOMPSON, RS
    THOMPSON, DC
    RIVARA, FP
    SALAZAR, AA
    PEDIATRICS, 1993, 91 (05) : 902 - 907
  • [30] Cost-effectiveness of population genomic screening
    Veenstra, David L.
    Guzauskas, Greg
    Peterson, Josh
    Hassen, Dina A.
    Snyder, Susan
    Hao, Jing
    Williams, Marc
    GENETICS IN MEDICINE, 2019, 21 (12) : 2840 - 2841